1. Antibody Response of Heterologous vs Homologous Messenger RNA Vaccine Boosters Against the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant: Interim Results from the PRIBIVAC Study, a Randomized Clinical Trial. (11th May 2022) Authors: Poh, Xuan Ying; Tan, Chee Wah; Lee, I Russel; Chavatte, Jean-Marc; Fong, Siew-Wai; Prince, Tessa; Hartley, Catherine; Yeoh, Aileen Y Y; Rao, Suma; Chia, Po Ying; Ong, Sean W X; Lee, Tau Hong; Sadarangani, Sapna P; Lin, Ray J H; Lim, Clarissa; Teo, Jefanie; Lim, Daniel R X; Chia, Wanni; Hiscox, Ju... Journal: Clinical infectious diseases Issue: Volume 75:Number 12(2022) Page Start: 2088 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cefazolin versus ceftriaxone as definitive treatment for Klebsiella pneumoniae bacteraemia: a retrospective multicentre study in Singapore. (27th January 2021) Authors: Lee, I Russel; Thein, Tun-Linn; Ang, Li Wei; Ding, Ying; Lim, Jonathan J; Bok, Chwee Fang; Mukherjee, Shilpa; Titin, Christina; Kalimuddin, Shirin; Archuleta, Sophia; Lye, David C Journal: Journal of antimicrobial chemotherapy Issue: Volume 76:Number 5(2021) Page Start: 1303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗